SAIL Fusion

SAIL Fusion

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SAIL Fusion is a private, commercial-stage medical device company addressing the significant unmet need in sacroiliac joint fusion. Founded in 2015 and based in Carlsbad, California, the company has developed the BowTie SI Fusion System, which applies proven orthopedic fusion principles to the SI joint via a uniquely shaped implant. Led by a seasoned executive team with deep experience in spine and orthopedics, the company is positioned to capture share in a growing market, though it faces competition from established players and must navigate the challenges of commercial adoption and potential regulatory scrutiny.

MusculoskeletalOrthopedicsSpine

Technology Platform

The BowTie SI Fusion System, an implant system applying AO Foundation joint fusion principles (minimal tissue disruption, thorough joint preparation, rigid fixation) specifically to the sacroiliac joint via a bowtie-shaped implant for multi-planar stability.

Opportunities

The SI joint fusion market is large and growing due to improved diagnosis and an aging population.
SAIL Fusion's principled, biomechanically-focused approach differentiates it from competitors and addresses a surgeon-identified need for a better solution.
The company's experienced leadership is well-positioned to capture market share and potentially become an attractive acquisition target.

Risk Factors

Intense competition from larger, well-established players with greater resources poses a significant commercial threat.
Success depends on unseating entrenched products and proving clinical superiority, which requires sustained commercial execution and positive long-term data.
As a private company, access to capital for scaling operations is also a key risk.

Competitive Landscape

The SI joint fusion market is competitive, dominated by players like SI-BONE (pioneer with the iFuse system), Medtronic, Globus Medical, and ZimVie. Competitors employ various technologies including percutaneous screws and triangular implants. SAIL Fusion differentiates by emphasizing the application of foundational AO fusion principles and the unique biomechanical stability of its bowtie implant.